IMR Press / RCM / Volume 25 / Issue 4 / DOI: 10.31083/j.rcm2504143
Open Access Review
Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management
Show Less
1 Department of Cardiovascular Sciences, University of Leicester, LE1 7RH Leicester, UK
2 Department of Cardiology, University Hospitals of Leicester NHS Trust, LE1 5WW Leicester, UK
3 John Walls Renal Unit, Leicester General Hospital, LE5 4PW Leicester, UK
4 School of Sport, Exercise and Health Sciences, Loughborough University, LE11 3TU Loughborough, UK
5 National Institute for Health Research Leicester Biomedical Research Centre, LE3 9QP Leicester, UK
*Correspondence: andre.ng@leicester.ac.uk (G. André Ng)
Rev. Cardiovasc. Med. 2024, 25(4), 143; https://doi.org/10.31083/j.rcm2504143
Submitted: 19 December 2023 | Revised: 29 January 2024 | Accepted: 19 February 2024 | Published: 9 April 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Chronic kidney disease (CKD) and atrial fibrillation (AF) are associated with significant cardiovascular morbidity and mortality. Recent studies have highlighted an increased prevalence and incidence of AF in patients with CKD. This article aims to provide a comprehensive review of current management strategies and considerations of treating atrial fibrillation with concomitant CKD. Potential electrophysiological mechanisms between AF and CKD are explored. Current evidence and literature focusing on pharmacological rate and rhythm control along with procedural intervention is reviewed and presented. The management of AF and CKD together is complex, but particularly pertinent when considering the close cyclical relationship in the progression of both diseases.

Keywords
atrial fibrillation
chronic kidney disease
anticoagulation
Funding
RG/17/3/32774/British Heart Foundation Programme
MR/S037306/1/Medical Research Council Biomedical Catalyst Developmental Pathway Funding Scheme
Figures
Fig. 1.
Share
Back to top